Arabic Arabic English English French French German German
dark

Public Meeting: Patient-Focused Drug Development for Huntington’s and Parkinson’s Disease (Part 4)

On September 22, 2015, FDA hosted a public meeting on Patient-Focused Drug Development for Huntington’s Disease and Parkinson’s Disease. FDA was interested in obtaining patient perspectives on the impact of Huntington’s Disease and Parkinson’s Disease on daily life and patient views on treatment approaches. For more information, visit the meeting webpage for Huntington’s Disease and Parkinson’s Disease.

Huntington’s Disease:
https://bit.ly/3xUWRXl

Parkinson’s Disease:
https://bit.ly/3vRuY0J

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Public Meeting: Patient-Focused Drug Development for Huntington’s and Parkinson’s Disease (Part 3)

Next Post

Tiziana Life Sciences Interview to Air on Bloomberg Television U.S. on the RedChip Money Report

Related Posts
Total
0
Share